Simple Blood Test on a Chip Could Help Diagnose Lung Cancer

Israeli blood test could make lung-cancer detection faster, more accessible

Israeli scientists have developed a blood test that can detect lung cancer without DNA sequencing, potentially offering a faster and less expensive tool to complement existing imaging methods, Tel Aviv University announced on Monday.“Our goal is to make blood tests for cancer diagnosis more accessible, simpler and less expensive without compromising accuracy,” said Professor Yuval Ebenstein of the university’s School of Chemistry. “We have devel…

Simple blood test on a chip could help diagnose lung cancer

Researchers at Tel Aviv University have developed a new method for diagnosing lung cancer: a simple, fast, low-cost blood test that does not require DNA sequencing. The method identifies a chemical fingerprint of cancer cells in the blood by analyzing cell-free DNA originating from those cells. In the study, the test distinguished between lung cancer patients and healthy individuals with a sensitivity of 93.1% and a specificity of 90.3% for patients with stage 2–4 disease.

Low-cost lab-on-a-chip blood test detects lung cancer without DNA

Lung cancer may soon be easier to detect with a technology that sounds more like a laboratory scanner than a conventional diagnostic test. Researchers at Tel Aviv University have developed a low-cost blood test that identifies lung cancer by reading the tumor’s biological “fingerprint” in fragments of DNA circulating through the bloodstream. Unlike many liquid-biopsy systems, the method does not require DNA sequencing, potentially making it fast…

Low-cost Blood Test on a Chip Diagnoses Lung Cancer Without DNA Sequencing

The new technology identifies the tumor’s biological fingerprint with more than 90% accuracy and could complement CT scans in monitoring patients’ response to treatment. Researchers at Tel Aviv University have developed a fast, low-cost blood test that diagnoses lung cancer by identifying a chemical fingerprint in cell-free DNA, bypassing the need for DNA sequencing. The study, published in Nature Precision Oncology, demonstrates that the test d…